Skip to content

Supraglottic Airway for Resuscitation in Preemies

Supraglottic Airway Interface for Positive Pressure Ventilation During Delivery Room Resuscitation of Premature Infants: A Pilot Feasibility Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07419438
Acronym
SUPREEMIE
Enrollment
20
Registered
2026-02-19
Start date
2026-03-13
Completion date
2026-10-01
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery Room Resuscitation, Laryngeal Mask, Laryngeal Mask Airways, Neonatal Resuscitation, Positive Pressure Ventilation, Premature Neonates, Respiratory Failure, Supraglottic Airway

Keywords

Respiratory failure, Premature neonates, Delivery Room Resuscitation, Positive pressure ventilation, Neonatal resuscitation, Supraglottic Airway, laryngeal mask, Laryngeal Mask Airways

Brief summary

The goal of this single-arm intervention trial is to learn whether using a supraglottic airway (SA) as the primary interface for positive pressure ventilation (PPV) is feasible during delivery room resuscitation of premature infants. This study will be conducted in premature infants born between 29 0/7 and 33 6/7 weeks' gestation who require PPV at birth. The main question it aims to answer is: Is it feasible to use a supraglottic airway as the primary interface to provide effective PPV during delivery room resuscitation in 29 0/7 to 33 6/7 weeks' gestation premature infants? Participants will (1)Be screened prenatally and have informed consent obtained from the birth parent prior to delivery; (2)Be rescreened for eligibility on the day of delivery before receiving the study intervention; (3)Receive PPV using a supraglottic airway as the primary ventilation interface if resuscitation is required at birth; and (4)Have clinical and procedural data collected during delivery room resuscitation and for up to 24 hours after birth.

Interventions

OTHERSupraglottic Airway

Use of a supraglottic airway as the primary interface for delivery of positive pressure ventilation during neonatal resuscitation.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Days to 1 Days
Healthy volunteers
No

Inclusion criteria

* Gestational age 29 0/7 to 33 6/7 weeks at birth * Estimated fetal weight \>/= 1000 grams at birth * Clinical decision to initiate PPV * Parental informed consent

Exclusion criteria

* Major anomalies or aneuploidy * Palliative care planned or considered * Not resuscitated in the infant resuscitation room

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Supraglottic Airway as Primary Ventilation InterfaceImmediately after birth (up to 10 minutes of life)Feasibility defined as successful use of a supraglottic airway as the primary interface to deliver positive pressure ventilation for up to 10 minutes of life or until discontinuation of positive pressure ventilation, without need for immediate escalation to an alternative airway interface.

Secondary

MeasureTime frameDescription
Time to Supraglottic Airway Placement During ResuscitationImmediately after birthTime in minutes from birth to placement of the supraglottic airway as the primary interface for delivery of positive pressure ventilation during delivery room resuscitation.
Duration of Supraglottic Airway Use During ResuscitationImmediately after birthTotal duration in minutes that the supraglottic airway is used as the primary interface to deliver positive pressure ventilation during delivery room resuscitation.

Countries

United States

Contacts

CONTACTSura Lee
sura.lee@pennmedicine.upenn.edu215-873-9339

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026